I rritable bowel syndrome (IBS) is a common functional gastrointestinal disorder, which is a heterogeneous condition with multiple etiologies, including abnormal reactions related to foods. 1, 2 Indeed, many patients with IBS commonly report adverse reactions against certain foods. 3, 4 Moreover, many studies have investigated the role of food allergies in patients with IBS [5] [6] [7] [8] ; however, the underlying mechanisms related to certain foods have not been fully elucidated. In this issue of Gastroenterology, the study by Fritscher-Ravens et al 9 provides evidence of abnormal reactions to individual foods and associated pathophysiologic changes in patients with IBS.
Low-grade mucosal inflammation is now recognized as a pathophysiologic feature in IBS 10, 11 and a variety of mechanisms may contribute to this, including diet. Certain foods may trigger an aberrant immune reaction and/or can increase intestinal permeability in patients with IBS. 6, [12] [13] [14] Indeed, several studies have shown that in more than one-half of patients with IBS, their symptoms worsened after consuming specific foods such as wheat products, cow's milk, soy sauces, and eggs. 6, 14 Moreover, several studies demonstrated that elimination diets for fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) and other foods are effective for reducing IBS symptoms, in particular when patients suspect that their gastrointestinal symptoms are due to certain foods. [15] [16] [17] Because food allergies are generally caused by IgE-mediated type 1 hypersensitivity, several studies have tried to identify systemic responses to food antigens with skin prick tests or Ig E antibodies in patients with IBS. [18] [19] [20] The results of these studies were inconclusive, but questions remain as to whether abnormal responses to foods could be localized and limited to the intestinal mucosa.
Several studies used food allergen provocation tests, in which food allergens were injected into the cecal or rectal mucosa. 5, 6, 8, 21 In these studies, about two-thirds of patients with IBS showed mucosal wheal and flare reactions along with increased mast cell and eosinophil activation, whereas healthy controls did not have these reactions. Furthermore, with a small number of cases, Fritscher-Ravens et al 8 examined the structural/functional changes of the intestinal mucosa, by using confocal laser endomicroscopy for real-time observation in patients with IBS and controls. They found that about two-thirds of patients with IBS showed abnormal mucosal changes including the formation of epithelial leaks/gaps and the widening of intervillous spaces after food challenge. About two-thirds of patients with IBS who had abnormal mucosal reactions to certain foods showed improvement of IBS symptoms after a 12-month exclusion diet. These findings indicated that hypersensitivity reactions against certain food allergens take place in the intestinal mucosa in a subset of patients with IBS. Consistent with these findings, Vazquez-Roque et al 7 also showed that a glutencontaining diet increased intestinal permeability in patients with IBS. Further, they found that patients with IBS on the gluten-containing diet had a decreased expression of zonula occludens 1, claudin-1, and occludin in rectosigmoid mucosa. Wheat, which has gluten in it, is one of the food antigens used in the study of Fritscher-Ravens et al 9 in the current issue of Gastroenterology.
Fritscher-Ravens et al 9 evaluated the underlying cellular and biochemical pathophysiology of atypical food allergies in a substantial number of patients with IBS who suspected their symptoms were related to food ingestion. Among patients who completed the study, 70% showed a positive reaction as demonstrated by confocal laser endomicroscopy, which was defined as a postchallenge increase of epithelial leaks with the secretion of fluorescein-labeled plasma into the lumen and the presence of fluorescent signal between enterocytes. Moreover, patients had improvement of IBS symptoms when they excluded those foods to which they reacted. More important, they showed that the confocal laser endomicroscopy positive patients with IBS had more intraepithelial lymphocytes, up-regulated claudin-2 expression, decreased occludin protein, and higher eosinophilic cationic protein. These changes, therefore, reveal that a subset of patients with IBS had abnormal intestinal mucosal responses to food resulting in dysfunction of the barrier.
This study demonstrates the frequency of, a mechanism for, and the benefit of avoidance of reactive foods in patients with IBS. This work provides support for the identification of, and subsequent exclusion of specific foods as a treatment for IBS. This approach of identification and then exclusion differs from the empiric trials of diets that more broadly limit food categories such as FODMAPs or high fiber foods. 15, 16, 22 However, this field is still in its infancy, and further large studies are warranted to fully reveal the relationship of dietary factors, innate and adaptive immune responses, and mucosal interactions that occur in IBS. Understanding the structural changes in small intestinal mucosa provides the opportunity of targeting this effect as a therapeutic alternative to the often not so simple food avoidance. T he mechanisms of immune activation in eosinophilic esophagitis (EoE) continue to be delineated and triggering antigens can be challenging to pinpoint. Whether antigen drives esophageal eosinophil accumulation from the outside in via the lumen, from the inside out via systemic immune signals, or both, remains enigmatic. In this issue of Gastroenterology, a study led by David Katzka and colleagues 1 at the Mayo Clinic reports the penetration of dust mite antigen into the esophageal epithelium of adults with EoE. Patients with EoE (79%) but none of the controls had detectable epithelial staining for Dermatophagoides farinae protein. This group previously reported local gluten accumulation in the EoE esophagus. 2 The observation of topical antigen deposition has intriguing implications. First, it speaks to the potential for an outside-in local immune activation. Second, it suggests that local antigen presence might be a surrogate marker for lost esophageal barrier function. Third, it is possible that the presence or absence of esophageal antigen could gauge adherence to prescribed regimens, such as gluten avoidance.
EoE is a delayed T helper type 2 cell (Th2)-mediated hypersensitivity involving both innate and adaptive immune responses to what should be benign antigens. Environmental adjuvants or the intrinsic protease activity of aeroallergens, such as house dust mite and cockroach, can break down epithelial barriers and unleash a protective immune cascade. House dust mite has abundant protease activity including cysteine and trypsin-, chymotryptsin-, and collagenolytic-like serine proteases. 3 There is clinical and murine model evidence that dust mite antigen can drive EoE. 4, 5 When coupled with the observation that a loss of serine protease inhibitors such as SPINK7 6 can singularly promote epithelial barrier dysfunction and eosinophil infiltration, it becomes immunologically plausible that local antigen exposure could be integral to EoE instigation and/or exacerbation. Epithelial breakdown would allow local antigen presentation by cells such as dendritic cells and macrophages. Given the underlying concurrent atopic diatheses prominent in patients with EoE, 7 including those in this study, the immune system is already primed for a Th2-dominant response. In the face of epithelial insult, innate immune cells such as group 2 innate lymphocytes are chemoattracted, activated by thymic stromal-derived lymphopoietin and IL-33, and can initiate an early response in an antigen unrestricted manner. 8 In the later immune phase, resident and infiltrating T cells including
